R2 in the Treatment of Follicular Lymphoma Grade 1-3A
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 06 Nov 2019 Interim results (n=68) assessing lenalidomide plus rituximab in patients with newly diagnosed follicular lymphoma, released in 61st Annual Meeting and Exposition of the American Society of Hematology.
- 04 Jul 2019 Status changed from not yet recruiting to recruiting.
- 29 Oct 2018 New trial record